Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9AKH2
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.619 |
CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.375 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.622 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.619 |
CLV_PCSK_PC1ET2_1 | 268 | 270 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 296 | 298 | PF00082 | 0.622 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 268 | 272 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 303 | 307 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.648 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.678 |
DEG_SPOP_SBC_1 | 56 | 60 | PF00917 | 0.677 |
DOC_CKS1_1 | 304 | 309 | PF01111 | 0.517 |
DOC_CYCLIN_yCln2_LP_2 | 149 | 155 | PF00134 | 0.447 |
DOC_MAPK_MEF2A_6 | 217 | 226 | PF00069 | 0.376 |
DOC_MAPK_MEF2A_6 | 277 | 286 | PF00069 | 0.355 |
DOC_PP2B_LxvP_1 | 149 | 152 | PF13499 | 0.447 |
DOC_PP2B_LxvP_1 | 271 | 274 | PF13499 | 0.447 |
DOC_PP4_FxxP_1 | 304 | 307 | PF00568 | 0.522 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.360 |
DOC_USP7_MATH_1 | 206 | 210 | PF00917 | 0.322 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.614 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.378 |
DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.469 |
LIG_14-3-3_CanoR_1 | 277 | 281 | PF00244 | 0.378 |
LIG_14-3-3_CanoR_1 | 297 | 307 | PF00244 | 0.288 |
LIG_14-3-3_CanoR_1 | 86 | 94 | PF00244 | 0.333 |
LIG_BRCT_BRCA1_1 | 300 | 304 | PF00533 | 0.477 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.378 |
LIG_FHA_1 | 241 | 247 | PF00498 | 0.355 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.335 |
LIG_FHA_2 | 159 | 165 | PF00498 | 0.434 |
LIG_FHA_2 | 288 | 294 | PF00498 | 0.546 |
LIG_LIR_Apic_2 | 176 | 182 | PF02991 | 0.398 |
LIG_LIR_Apic_2 | 276 | 281 | PF02991 | 0.411 |
LIG_LIR_Apic_2 | 301 | 307 | PF02991 | 0.531 |
LIG_LIR_Gen_1 | 243 | 252 | PF02991 | 0.336 |
LIG_LIR_Gen_1 | 309 | 315 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 243 | 248 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 309 | 315 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 33 | 39 | PF02991 | 0.559 |
LIG_PTB_Apo_2 | 188 | 195 | PF02174 | 0.408 |
LIG_PTB_Phospho_1 | 188 | 194 | PF10480 | 0.408 |
LIG_SH2_CRK | 180 | 184 | PF00017 | 0.359 |
LIG_SH2_CRK | 278 | 282 | PF00017 | 0.408 |
LIG_SH2_NCK_1 | 215 | 219 | PF00017 | 0.378 |
LIG_SH2_NCK_1 | 288 | 292 | PF00017 | 0.550 |
LIG_SH2_STAP1 | 215 | 219 | PF00017 | 0.447 |
LIG_SH2_STAP1 | 288 | 292 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 278 | 281 | PF00017 | 0.408 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.465 |
LIG_SUMO_SIM_par_1 | 279 | 285 | PF11976 | 0.355 |
LIG_SUMO_SIM_par_1 | 98 | 104 | PF11976 | 0.411 |
LIG_SxIP_EBH_1 | 236 | 246 | PF03271 | 0.408 |
LIG_TRAF2_1 | 24 | 27 | PF00917 | 0.514 |
MOD_CK1_1 | 209 | 215 | PF00069 | 0.346 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.188 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.704 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.614 |
MOD_CK2_1 | 158 | 164 | PF00069 | 0.434 |
MOD_CK2_1 | 287 | 293 | PF00069 | 0.537 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.341 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.704 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.568 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.378 |
MOD_GSK3_1 | 209 | 216 | PF00069 | 0.354 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.337 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.454 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.726 |
MOD_GSK3_1 | 299 | 306 | PF00069 | 0.508 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.624 |
MOD_N-GLC_1 | 30 | 35 | PF02516 | 0.725 |
MOD_N-GLC_1 | 49 | 54 | PF02516 | 0.401 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.353 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.546 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.560 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.734 |
MOD_PKA_2 | 276 | 282 | PF00069 | 0.359 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.329 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.335 |
MOD_Plk_4 | 206 | 212 | PF00069 | 0.385 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.373 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.378 |
MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.468 |
TRG_DiLeu_BaLyEn_6 | 219 | 224 | PF01217 | 0.356 |
TRG_DiLeu_BaLyEn_6 | 4 | 9 | PF01217 | 0.644 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.351 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.414 |
TRG_ER_diArg_1 | 22 | 25 | PF00400 | 0.634 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.608 |
TRG_ER_diArg_1 | 85 | 88 | PF00400 | 0.402 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5M3 | Leptomonas seymouri | 68% | 100% |
A0A1X0NKR5 | Trypanosomatidae | 54% | 100% |
A0A3R7M8G7 | Trypanosoma rangeli | 58% | 100% |
A0A3S5H5J0 | Leishmania donovani | 93% | 98% |
A4H4B0 | Leishmania braziliensis | 81% | 100% |
A4HSI8 | Leishmania infantum | 90% | 98% |
C9ZUB5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 98% |
Q4QJD6 | Leishmania major | 88% | 100% |
V5BAS5 | Trypanosoma cruzi | 58% | 99% |